Influence of different dose-intensity navelbine plus cisplatin as the first-line treatment in patients with advanced non-small cell lung cancer

LI Zi-Ming; YU Yong-feng; LU Shun

doi:10.3969/j.issn.1009-0460.2008.02.004

Home>Articles>Influence of different dose-intensity navelbine plus cisplatin as the first-line treatment in patients with advanced non-small cell lung cancer

DOI: 10.3969/j.issn.1009-0460.2008.02.004

Influence of different dose-intensity navelbine plus cisplatin as the first-line treatment in patients with advanced non-small cell lung cancer

LI Zi-Ming

YU Yong-feng

LU Shun

Machine-generated Keywords：

Publication Date：2008-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 115-118 )

CHINESE CLINICAL ONCOLOGY

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2008,13(2)